Tag: estimates

Earnings Estimate Scorecard: MCHP – Analyst Blog

Filed in economy, euro, Gold Investing, Guidance, upgrade by on March 25, 2010 0 Comments

Last week, Microchip Technologies ( MCHP ) raised its outlook for the fourth quarter of fiscal 2010. The company now expects sales to be up 8% sequentially compared to the previous guidance of 3% – 7%. The revised guidance implies a revenue guidance of $270.1 million. Microchip earlier demonstrated solid growth in the third quarter, driven by strength across all three product lines − Microcontrollers, Analogs and Serial EEPROMs. Earnings per share are now estimated at 42 cents, up from the previous estimate of 39 – 41 cents. AGREEMENT- ESTIMATE REVISIONS Following the upgrade in outlook by management, estimates for Microchip have been on the rise. Nine out of the fourteen analysts covering the stock have raised their estimates for fiscal 2010 in the past thirty days while one analyst moved in the opposite direction. For fiscal 2011, nine out of the thirteen analysts covering the stock raised their estimates. There was no revision in the opposite direction. For the quarter ending March 2010, eleven out of the thirteen analysts covering the stock have upped their estimates. There was no revision in the opposite direction. MAGNITUDE CONSENSUS ESTIMATE TREND The current Zacks Consensus Estimate for 2010 is $1.11, up one cent in the past 30 days. For fiscal 2011, the current Zacks Consensus Estimate is $1.58, up four cents in the last thirty days, signaling a 41.28% year-over-year growth in the bottom line. Microchip has consistently met or exceeded its guidance. In the third quarter, the company delivered a positive surprise of 13.79% and a positive surprise of 9.09% in the second quarter. On an average, Microchip has come ahead of the Zacks Consensus Estimate by 10.01% in the last four quarters. The current Zacks Consensus Estimate for the fourth quarter is 37 cents, up by a penny in the last 30 days. NEUTRAL ON MICROCHIP Management indicated that demand for its products continues to be robust in Asia and Europe. In particular, China continues to be strong after the New Year while Europe is expected to exceed seasonally strong March quarter results. Microchip is expected to have record bookings in the current quarter, which bode well for the next quarter. With the economy showing signs of recovery and rising chip sales, Microchip continues to see excellent design win traction in strategic product lines. This should boost the top line. Meanwhile, in response to the economic downturn, Microchip implemented certain cost reduction measures (headcount reduction, shutting down of fabs, reducing production levels and a pay-cut for its employees).

Continue Reading »

Teijin Sales Operating Profit to Beat Forecasts Nikkei Says

Filed in Gold Holdings by on March 23, 2010 0 Comments

Teijin Ltd. is likely to beat itssales and operating profit forecasts for the fiscal year endingthis month, the Nikkei newspaper reported, without saying how itarrived at the estimates. Operating profit will be about 18billion yen ($199 million), hi Teijin Sales Operating Profit to Beat Forecasts Nikkei Says

Continue Reading »

The Trillion Dollar “Bargain”

Filed in Gold by on March 20, 2010 0 Comments

Credit where credit is due: the latest White House argument for health reform is compelling. The administration has figured out how to sell a massive expansion of government as “fiscally conservative.” On Thursday, the CBO released estimates for the President’s bill, projecting an overall cost savings. The White House now trumpets that the health-reform bill will lead to the biggest legislated reduction of the deficit since the first term of the Clinton Presidency. “You have to spend money to save money” is a popular expression. No doubt, that’s what the White House is hoping Americans will think when they read… Original Article: Forum: News/Activism

Continue Reading »

CBO Revises Estimate of the Cost of Senate Health Care Bill Upwards by $50 Billion

Filed in Gold Bullion prices by on March 19, 2010 0 Comments

The Congressional Budget Office (CBO) has revised its estimates of discretionary spending provisions in the Senate health care bill – adding more than $50 billion to the price tag of reform, cutting in half the potential savings of the Senate bill. In a March 15 memo, CBO said it had identified “at least $50 billion in specified and estimated authorizations of discretionary spending that might be involved in implementing” the Senate bill. Discretionary spending is the use of funds not required by law, which are inserted in periodic appropriations bills that Congress passes to set the spending level of the… Original Article: Forum: News/Activism

Continue Reading »

(CIEN) Ciena Analysts Maintain Neutral Ratings After Revisions

Filed in Gold Investing, silver by on March 18, 2010 0 Comments

Following the release of Ciena Corporation’s (CIEN) first quarter fiscal 2010 results on March 4, 2010, analysts have made both positive and negative revisions to their estimates. Linthicum, Maryland-based CIENA is an original equipment manufacturer (OEM) …

Continue Reading »

Who’s still biased? (study finds diversity training does not work)

Filed in Gold, Gold Bullion prices by on March 16, 2010 0 Comments

If you work at a large company, and especially if you manage other people, chances are you’ve gone through diversity training. The vast majority of the Fortune 500 and, by some estimates, the majority of American employers offer diversity training programs for their employees. Many make such training mandatory. The amount of money spent on it in the United States runs into the billions. The courses vary widely, in content and duration and method and philosophy: Some are short videos followed by structured discussions, some are multiday retreats, some are informational, teaching participants about their “diversity circle” and the difference… Original Article: Forum: News/Activism

Continue Reading »

Teamsters yell ‘cut’ on plum movie-set jobs

Filed in Gold Bullion prices by on March 15, 2010 0 Comments

–snip– The much-sought-after jobs, on movie shoots for such recent local projects as Rocky Balboa, Law Abiding Citizen, and Marley and Me, are few and far between. Estimates are that between 60 and 70 members of the 2,400-member union work on movies. The jobs are subject to the vagaries of the movie-making business. But they pay extremely well. A driver makes about $2,500 a week plus overtime. “Captains,” union members assigned to oversee drivers, earn about $3,300 a week plus overtime Original Article: Forum: News/Activism

Continue Reading »

ENSCO: A Mixed Bag of Revisions – Analyst Blog

Filed in Debt, Gold Investing, Guidance, silver by on March 8, 2010 0 Comments

Despite modestly better-than-expected fourth quarter results, earnings estimates of the first two quarters and full-year 2010 for ENSCO International plc ( ESV ) are on a downtrend. However, for 2011, estimates are on the rise. Fourth Quarter Recap Earnings per share from continuing operations came in at $1.24 in the fourth quarter of 2009, topping the Zacks Consensus Estimate of $1.22. However, on a year-over-year basis, ENSCO’s earnings per share declined 42%, while revenues were down 17.4% to $499.6 million. For more details please see our earnings blog by clicking on this link . Key Facts •    With the redomestication to the UK, the company currently expects its 2010 effective tax rate will be approximately 16% to 17% versus 19% in the last year. As the restructuring activities are expected to wrap up by mid-year, ENSCO will not get the full benefit of these changes in 2010. However, it expects to achieve an effective tax rate below 15% in 2011. •    ENSCO’s 2010 deepwater revenue is estimated to be about $525 million, down from the previous guidance of $600 million. Total costs for 2010 were guided up 6% and total capital expenditures were guided down 14% to $740 million in 2010. •    The company foresees a mixed bag in jackup utilization this year. As a result of this, 2010 jackup utilization rate will average around 72%, essentially flat with the fourth quarter of 2009. Estimate Revisions Trend Based on the company’s performance and 2010 guidance, several analysts following the stock have revised their estimates. Over the past 30 …

Continue Reading »

Solarfun Enters Oversold Territory – Zacks Tale of the Tape

Filed in silver by on February 26, 2010 0 Comments

Solarfun Power Holdings Co. Ltd. ’s ( SOLF ) share price has entered into oversold territory with a stochastic value of 14.74. Analysts have been increasing their estimates on the company’s earnings for 2010, sending the Zacks Consensus Estimate up 8 cents over the past 2 months to 67 cents per share. Solarfun Power Holdings is a Zacks #1 Rank (“Strong Buy”) company. “SOLF” Free Stock Analysis: Buy? Sell? Hold? Zacks Investment Research

Continue Reading »

Weakening Outlook on Sanofi – Analyst Blog

Filed in Gold Investing, silver by on February 16, 2010 0 Comments

We recently downgraded our recommendation on Sanofi-Aventis ( SNY ) to Underperform from our earlier Neutral recommendation. Although Sanofi’s fourth-quarter earnings came in a couple of cents above the Zacks Consensus Estimate, we are concerned about the company’s high exposure to generic risk on many of its leading franchises. We see generic risk to products like Avapro, Allegra, Lovenox, Eloxatin, Delix, Taxotere, Plavix and Ambien all keeping a lid on shares. With Eloxatin facing generics from 2009, the next wave of generic erosion will occur in 2010 when Taxotere loses exclusivity. The generic risk to Lovenox is the most concerning and, if it were to materialize, would cause significant problems for Sanofi. Although the inability of generic manufacturers in getting a Lovenox substitute approved is somewhat encouraging, there remains a risk that Lovenox sales will be compromised in the future. Lovenox accounted for 10.4% of total sales in 2009 and a generic alternative would be devastating. Recent revisions in 2010 earnings estimates for Sanofi have been in both directions, with a strong downward (negative) bias. Over the last 30 days, 6 of the 8 analysts following the stock have reduced their estimates for fiscal 2010, with only one analyst moving in the opposite direction. Over the last 7 days, 3 of the 8 analysts covering the stock have lowered their estimates for fiscal 2010 with just one analyst moving in the opposite direction. On balance, the estimate is down 13 cents per ADS in the last 7 days. If annual results come in line with expectations, 2010 EPADS would be 3.8% below the year-earlier level. The year-over-year decline is due to the impact of genericization of lead franchises. For the first quarter of 2010, the Zacks Consensus Estimate is $1.17, representing year-over-year growth of 6.4%. Over the last 30 days, 1 of the 3 analysts following the stock has reduced their estimates for fiscal 2010, with no movement in the opposite direction. A similar trend was observed in the last 7 days. On balance, the estimate for the first quarter of fiscal 2010 is down 2 cents per ADS. In terms of earnings surprises, Sanofi had a modest positive surprise (2.17%) in the fourth quarter of 2009 and a 4% positive surprise in the third quarter of 2009, with the four-quarter average of positive 12.78%. This means that, on an average, Sanofi has come ahead of the Zacks Consensus by 12.78% over the last four quarters. Our short-term rating on Sanofi is ‘Hold’ (Zacks #3 Rank) – we expect the company to perform in-line with expectations in the first quarter of 2010. We believe the vaccines segment, which drove fourth quarter revenues, will help boost performance in the first quarter as well. However, longer-term, we have an Underperform recommendation on Sanofi due to our concerns regarding generic competition. While new product launches should make significant revenue contributions in the early part of the decade, they will not be enough to compensate for increased generic erosion. Read the full analyst report on “SNY” Zacks Investment Research

Continue Reading »

Parametric Technology Q1 Profit Surges; Tops Estimates

Filed in Gold Holdings, Gold Investing by on January 26, 2010 0 Comments

Tuesday, Paramtc Technology Corp. (PMTC), a provider of product lifecycle management software solutions, reported a sharp increase in net income for the first quarter. The higher profit was mainly due to the increase in license revenue which in-turn Parametric Technology Q1 Profit Surges; Tops Estimates

Continue Reading »

Parametric Technology Q1 Profit Surges; Tops Estimates

Filed in Gold Holdings by on January 26, 2010 0 Comments

Tuesday, Paramtc Technology Corp. (PMTC), a provider of product lifecycle management software solutions, reported a sharp increase in net income for the first quarter. The higher profit was mainly due to the increase in license revenue which in-turn Parametric Technology Q1 Profit Surges; Tops Estimates

Continue Reading »